Clinical feasibility of individualized therapy in leukemia and lymphoma patients
Standard therapy for advanced recurring aggressive, hematological malignancies, such as leukemias and lymphomas, have a limited effect with patients experiencing short survival times. A study at the Vienna General Hospital ...
Oct 12, 2021
0
94